Can You Heal Stage 3 Fatty Liver? Resmetirom Vs. Intermittent Fasting

Fatty liver disease is rising silently—affecting over a quarter of adults worldwide—yet many don’t know they have it until the damage is severe. By the time it reaches Stage 3, also called advanced fibrosis, the stakes are high. The liver is scarred, metabolism is disrupted, and the risk of life-threatening complications like cirrhosis and cancer increases sharply.

Fortunately, science is catching up.

In 2024, the U.S. FDA approved Resmetirom (brand name: Rezdiffra)—the first drug specifically designed to treat non-alcoholic steatohepatitis (NASH) with moderate to advanced fibrosis. Clinical trials showed that it can help reverse some of the damage by lowering liver fat and even regressing fibrosis.

But this breakthrough medication isn’t the only option. Another powerful tool—intermittent fasting—has been gaining attention. Not only is it free and accessible, but growing evidence also shows that intermittent fasting can reduce liver fat, improve insulin resistance, and potentially help reverse fatty liver, even in its more serious stages.

In this article, we’ll explore:

What Stage 3 fatty liver means and why it matters
How the condition is diagnosed and monitored
How Resmetirom works and what clinical trials say
The different types of intermittent fasting and their impact
A direct comparison between the drug and natural methods

Can a prescription pill and a simple eating pattern both help rescue the liver? Let’s find out.

🟨 II. What Is NAFLD and Its Stages?

Non-Alcoholic Fatty Liver Disease (NAFLD)—now also called Metabolic dysfunction-associated steatotic liver disease (MASLD)—is a condition where fat builds up in the liver of people who drink little or no alcohol. It’s closely tied to obesity, insulin resistance, high blood sugar, and high triglycerides.

NAFLD progresses through four main stages:

🟢 Stage 1: Simple Steatosis (Fatty Liver)

What happens: Fat accumulates in liver cells, but there’s no inflammation or damage yet.
Symptoms: Usually none. It’s often found incidentally on ultrasound.
Significance: This stage is reversible and has a low risk of progression if caught early and addressed with lifestyle changes.

🟡 Stage 2: NASH (Non-Alcoholic Steatohepatitis)

What happens: Fat in the liver triggers inflammation and damage to liver cells.
Symptoms: May include fatigue, mild right upper abdominal discomfort, or elevated liver enzymes (ALT/AST).
Significance: This is the turning point from a “silent” condition to one with potential long-term consequences. Inflammation increases the risk of fibrosis and scarring.

🟠 Stage 3: Fibrosis (Advanced NASH)

What happens: The liver starts to develop fibrous scar tissue. This interferes with blood flow and liver function, though the liver is still functioning.
Symptoms: Still often silent, but some may have fatigue, swelling, or vague digestive issues.
Significance: This is a dangerous yet potentially reversible stage. If untreated, it may progress to cirrhosis. At this stage, intervention is critical.

🔴 Stage 4: Cirrhosis

What happens: Extensive scarring replaces healthy liver tissue. Liver function is severely impaired.
Symptoms: May include abdominal swelling, confusion, yellowing of the eyes or skin (jaundice), and easy bruising.
Significance: This stage is largely irreversible. It raises the risk of liver failure and liver cancer (hepatocellular carcinoma) and may require a transplant.

⚠️ Why Staging Matters

Understanding which stage a patient is in helps guide treatment.

Stage 1–2: Often managed with diet, exercise, and weight loss.
Stage 3: May require medication or intensive lifestyle changes.
Stage 4: Needs specialist care and often long-term management or surgical options.

🟦 III. How Is Fatty Liver Monitored?

Because fatty liver disease often shows no symptoms until it becomes severe, early detection and regular monitoring are essential, especially for those at risk or already in Stage 3 (fibrosis).

Here are the most common tools used to diagnose and track the progression or improvement of fatty liver disease:

🖥️ A. Imaging Tests

1. Ultrasound

What it shows: Bright liver appearance if there’s fat.
Limitations: Cannot detect fibrosis accurately.
Use: First-line test, widely available and low cost.

2. FibroScan (Transient Elastography)

Measures liver stiffness (in kilopascals or kPa), which correlates with fibrosis.
Also provides CAP score (Controlled Attenuation Parameter) to estimate fat content.
Use: Non-invasive, no radiation, ideal for tracking fibrosis.

3. MRI-PDFF (Proton Density Fat Fraction)

Gold standard for liver fat quantification.
Sensitive to even small changes in fat content.
Limitation: Expensive and not always available.

🧪 B. Blood-Based Tests

1. Liver Enzymes

ALT (alanine aminotransferase) and AST (aspartate aminotransferase) rise with liver cell injury.
Note: Normal enzymes don’t rule out fatty liver or fibrosis.

2. Fibrosis Scoring Systems

These use age, platelet count, AST, ALT, and other values to estimate fibrosis:

FIB-4 Index
NAFLD Fibrosis Score
AST to Platelet Ratio Index (APRI)

These tools are useful for screening but not definitive for staging.

🧬 C. Liver Biopsy

Still the gold standard for confirming NASH and fibrosis stage.
Shows inflammation, ballooning, and scarring directly.
Limitations: Invasive, not routinely repeated unless absolutely necessary.

🔁 How Progress Is Measured Over Time

To see whether liver fat and fibrosis are improving:

Repeat FibroScan or MRI-PDFF every 6–12 months
Watch for decreasing liver stiffness and fat content
Monitor blood sugar, lipids, and weight
Track liver enzymes for signs of inflammation

Regular monitoring helps decide whether a patient is improving with lifestyle changes or needs medical therapy like Resmetirom. It also prevents progression to cirrhosis, which has much more serious consequences.

🟥 IV. The Dangers of Cirrhosis

Cirrhosis is the final, most severe stage of fatty liver disease—and once it sets in, the liver is permanently scarred. At this point, the structure and function of the liver are significantly impaired. While early-stage fatty liver may be reversible, cirrhosis is largely irreversible and brings a cascade of serious health risks.

🔄 What Happens in Cirrhosis?

Healthy liver tissue is replaced by scar tissue (fibrosis)
This disrupts blood flow and reduces the liver’s ability to:
- Detoxify the blood
- Produce essential proteins (like albumin and clotting factors)
- Store and process nutrients
- Metabolize drugs and hormones

⚠️ Health Risks of Cirrhosis

1. Liver Failure

The liver can no longer perform its life-sustaining functions.
Symptoms: fatigue, confusion, jaundice, ascites (fluid in the abdomen), and bleeding.

2. Portal Hypertension

Scarred tissue blocks normal blood flow → increased pressure in the portal vein.
Leads to:
- Esophageal varices (dilated veins that can rupture and bleed)
- Splenomegaly (enlarged spleen)
- Ascites

3. Hepatic Encephalopathy

The liver fails to clear toxins like ammonia → buildup in the brain.
Symptoms: confusion, personality changes, drowsiness, and in severe cases, coma.

4. Hepatocellular Carcinoma (Liver Cancer)

Cirrhosis is the strongest risk factor for liver cancer.
Requires lifelong screening with ultrasound and blood tests (AFP).

5. Need for Liver Transplant

In advanced cirrhosis (also called decompensated cirrhosis), the only remaining option may be a transplant.

🚨 Why Early Intervention Matters

Cirrhosis can take years to develop, but once it does, the complications are life-threatening. That’s why Stage 3 (fibrosis) is considered a critical window for intervention. At this point, reversing the course is still possible with the right tools—like Resmetirom or intermittent fasting—before cirrhosis sets in.

🟪 V. What Is Resmetirom and How Does It Work?

Resmetirom (brand name: Rezdiffra) is the first FDA-approved drug specifically designed to treat non-alcoholic steatohepatitis (NASH) with moderate to advanced fibrosis (Stages F2–F3). It represents a major step forward in managing a condition that was previously treated only with lifestyle changes and off-label medications.

🧪 What Kind of Drug Is It?

Resmetirom is a thyroid hormone receptor-β (THR-β) agonist. That means it mimics the effect of thyroid hormone, but in a liver-specific way.

Unlike thyroid hormone pills, Resmetirom targets only the liver and avoids stimulating the heart or bones.
It works inside liver cells to regulate genes involved in:
- Fat metabolism
- Cholesterol breakdown
- Inflammation reduction

⚙️ How Does It Work?

Resmetirom improves liver health through three main mechanisms:

Reduces Liver Fat (Steatosis)
- Increases fat burning inside liver cells
- Decreases the production and storage of new fat
Improves Cholesterol Levels
- Lowers LDL (“bad”) cholesterol and triglycerides
- Reduces levels of lipoprotein(a), a risk factor for heart disease
Reduces Inflammation and Fibrosis
- By lowering fat and oxidative stress, it indirectly reduces liver inflammation
- This, in turn, allows scar tissue (fibrosis) to stop progressing—and in some cases, regress

📊 What Do the Clinical Trials Say?

The most recent Phase 3 study published in The New England Journal of Medicine (2024) showed:

~30% of patients achieved resolution of NASH (inflammation + cell damage)
~25% showed improvement in liver fibrosis by at least 1 stage
Significant reductions in liver fat (MRI-PDFF) within 12 weeks
Also improved blood markers of inflammation and liver damage

Importantly, these results came from biopsy-confirmed patients with moderate to advanced NASH, a group for whom lifestyle change alone is often not enough.

💊 What Are the Side Effects?

Most side effects are mild and include:

Diarrhea
Nausea
Mild increase in heart rate
Some patients had thyroid function changes, but these were usually not clinically significant

Resmetirom is taken as a once-daily oral pill.

💵 Accessibility and Cost

Resmetirom (Rezdiffra) has a list price of approximately $47,000 per year, or around $3,900 per month without insurance. However, many patients pay far less, depending on their insurance coverage, copay assistance, or use of pharmacy discount programs.

For example, it is entirely possible—and even common—for some patients to pay around $400 per month. This lower cost may be due to:

Commercial insurance that covers a significant portion of the drug
Enrollment in Madrigal Pharmaceuticals’ copay savings program, which may reduce the monthly cost to as little as $10 during the first year
Use of GoodRx, SingleCare, or specialty pharmacy discounts

Prices vary widely depending on the insurance plan, eligibility for financial assistance, and the dispensing pharmacy. Patients are encouraged to check with their healthcare provider, pharmacist, or Madrigal’s patient support team to determine what their personal out-of-pocket cost will be.

In the next section, we’ll compare this promising but high-cost medication to an increasingly popular, drug-free—and much more affordable—approach: intermittent fasting.

While Resmetirom may cost hundreds to thousands of dollars per month, intermittent fasting is free, accessible to nearly everyone, and backed by a growing body of evidence showing its benefits for fatty liver disease.

🟨 VI. How Does Intermittent Fasting Help Fatty Liver?

Intermittent fasting (IF) is a powerful and natural method to reduce liver fat, improve insulin sensitivity, and lower inflammation—all of which are central to reversing fatty liver disease, including Stage 3 fibrosis.

Unlike medications, IF doesn’t require prescriptions or long-term pharmaceutical use. Instead, it works by changing the body’s metabolic environment in favor of fat burning and liver repair.

⚙️ How IF Works in the Liver

Switches the Body from Glucose to Fat for Fuel
- During fasting, insulin levels drop, allowing the body to burn stored fat—including fat stored in the liver (steatosis).
Lowers Inflammation and Oxidative Stress
- Studies show IF reduces inflammatory markers like TNF-α and IL-6, which are elevated in NASH.
Improves Insulin Sensitivity
- Insulin resistance is a key driver of fatty liver. IF helps muscles and the liver respond better to insulin.
Stimulates Autophagy (Cellular Cleanup)
- Fasting promotes autophagy, which clears damaged cells and reduces fibrosis progression.

📚 Supporting Evidence

A 2022 meta-analysis in Frontiers in Nutrition reviewed nine randomized controlled trials on IF and NAFLD. The findings:

All forms of IF reduced body weight, liver fat (MRI or ultrasound), and liver enzyme levels (ALT, AST)
IF improved lipid profiles and glucose metabolism
Some studies showed improvement in liver stiffness (FibroScan) and fibrosis scores

🕐 Types of Intermittent Fasting for NAFLD

Different IF patterns may suit different people. Here are the main ones:

🟠 1. Time-Restricted Eating (TRE)

Eat within a window (e.g., 8 hours), fast the remaining 16 hours.
Most practical and sustainable for beginners.
Benefits: weight loss, insulin improvement, reduced liver fat.
Eat a high-protein breakfast for better blood sugar control all day.

🟡 2. 5:2 Diet

Eat normally 5 days a week, consume only ~500–600 calories on 2 non-consecutive days.
Shown to reduce liver enzymes and visceral fat.

Fasting Mimicking Or 5:2 Diet? Discover The Best For You!

🔵 3. Alternate Day Fasting (ADF)

Fast every other day (0–500 kcal), eat normally on feeding days.
Effective but may be harder to maintain.
Strong effects on body weight, liver fat, and inflammation.

🏃‍♂️ Bonus: Add Aerobic Exercise

Combining IF with aerobic exercise amplifies benefits, including:
- Greater reduction in liver stiffness
- Enhanced fat oxidation
- Improved cardiovascular fitness

🔁 Summary of IF Effects on NAFLD

↓ Liver fat
↓ Inflammation
↓ Insulin resistance
↓ Fibrosis markers
↑ Weight loss
↑ Metabolic flexibility

⚠️ One Common Mistake to Avoid

While intermittent fasting can reset metabolism and improve liver health, a common mistake is eating large amounts of refined carbohydrates when the eating window begins. This can lead to a sharp post-meal blood sugar spike, defeating the metabolic benefits of fasting.

To prevent this:

Check your blood sugar 1 hour after eating; keep it below 155 mg/dL
At 2 hours, it should be below 140 mg/dL
This helps avoid postprandial hyperglycemia, which promotes inflammation, fat buildup, and fibrosis—even in those coming off a fast
Studies have shown that the 1 hour postprandial blood sugar is a more reliable predictor for the development of type 2 diabetes, cardiovascular disease, kidney dysfunction and a higher all-cause mortality.

Choosing low-glycemic, fiber-rich meals with healthy fats and protein during eating windows helps maintain the gains of intermittent fasting and supports liver healing.

Up next: A side-by-side comparison table of Resmetirom and different IF strategies for managing Stage 3 fatty liver.

🟦 VII. Comparison Table: Resmetirom vs. Intermittent Fasting Approaches

Criteria	Rezdiffra (Resmetirom)	Intermittent Fasting (IF)
Mechanism of Action	Activates thyroid hormone receptor-β (THR-β) in the liver → increases fat burning, reduces liver fat and inflammation	Triggers lipolysis, lowers insulin, improves metabolic flexibility → reduces liver fat and improves insulin resistance
Targeted Effect	Specifically developed to treat NASH with fibrosis (F2–F3)	Broadly effective for NAFLD and early NASH; evidence for reversal of advanced fibrosis is emerging
Clinical Trial Evidence	✅ Large Phase 3 randomized trials; NASH resolution ~26–30%; fibrosis regression ~25%	✅ Human trials show reduction in liver fat (30–60% by MRI); fibrosis improvement is plausible but not yet biopsy-confirmed in large RCTs
Onset of Effect	Measurable effect in 12–52 weeks (depending on fibrosis and biomarkers)	MRI studies show fat reduction in 2–6 months; long-term studies show metabolic and fibrosis benefits in 12–24 months
Effects on Whole-Body Metabolism	Primarily targets liver metabolism; improves lipid profile and reduces inflammatory markers	Improves insulin sensitivity, lowers inflammation, enhances mitochondrial function, increases autophagy (↑ATG-5), and regulates FGF-21
Side Effects	Mild diarrhea, nausea, fatigue; potential thyroid suppression, especially at high doses	Usually none if properly followed; risks include hypoglycemia, electrolyte imbalance (esp. in diabetics or elderly)
Cost	💸 Expensive; may cost thousands monthly (specialist prescription only)	🆓 Free (cost-saving); no drugs needed
Ease of Use	Daily oral medication; may require monitoring of thyroid and lipids	Requires behavioral discipline; may not be suitable for everyone
FDA/EMA Approval	✅ Yes, for non-cirrhotic NASH with F2–F3 fibrosis	❌ Not a drug; but endorsed by liver health guidelines for NAFLD management
Long-Term Data	2-year follow-ups show liver stiffness reduction and fibrosis reversal in many patients	Long-term fasting studies show weight loss, metabolic improvements, reduced liver fat; fibrosis regression needs more study

To help patients and clinicians evaluate their options, here is a simplified comparison of Resmetirom (Rezdiffra) and three major types of intermittent fasting (IF)—Time-Restricted Eating (TRE), the 5:2 Diet, and Alternate Day Fasting (ADF)—specifically for treating Stage 3 fatty liver disease (advanced fibrosis in NAFLD/NASH).

Feature	Resmetirom (Rezdiffra)	Time-Restricted Eating (16:8)	5:2 Diet	ADF (Alternate-Day Fasting) + Exercise
Mechanism	Liver-specific thyroid receptor β agonist	Fasting triggers fat-burning and insulin sensitivity	Caloric restriction 5 days weekly	Caloric restriction every other day +fat burning
Main Action on Liver	↓ Liver fat, ↓ fibrosis, ↓ inflammation	↓ Liver fat, ↓ insulin resistance	↓ Liver enzymes, ↓ Liver fat	↓ Liver fat (strongest, ↓ inflammatory markers
Effectiveness in Stage 3	Shown to improve fibrosis by ≥1 stage in ~25% of users	Can improve liver stiffness (FibroScan) in some studies	Shown to reduce liver enzymes and visceral fat	Effective in reducing liver fat and body weight
Weight Loss	Moderate, not required for effect	Mild to moderate	Moderate	High (but less sustainable)
Cholesterol Benefits	↓ LDL, ↓ triglycerides, ↓ Lp(a)	↓ LDL, ↑ HDL (variable)	↓ triglycerides	↓ total cholesterol and LDL
Requires Prescription?	✅ Yes	❌ No	❌ No	❌ No
Side Effects	Diarrhea, nausea, mild thyroid effects	Hunger early on, social eating challenges	Headache, fatigue on fasting days	Lightheadedness, fatigue, hard to sustain
Cost	💵💵💵 (expensive without insurance)	Free	Free	Free
Compliance Rate	High when monitored	High with support	Moderate	Lower (harder to sustain long-term)
Add-On Exercise Benefit	May improve outcomes if combined	👍 Yes	👍 Yes	👍 Yes
Long-Term Data Available	Limited to 12–18 month trials	Growing body of studies	Moderate number of RCTs	Fewer long-term studies

✅ Key Takeaways:

Resmetirom is ideal for biopsy-proven NASH with fibrosis, especially when rapid fibrosis reduction is needed.
Intermittent fasting, particularly TRE and 5:2, offers a free, accessible, and evidence-supported strategy to reduce liver fat and inflammation.
Combination approaches (IF + exercise ± medication) may offer the best results, especially in motivated patients.

🟩 VIII. Conclusion

Stage 3 non-alcoholic fatty liver disease (NAFLD) is a serious, but still reversible condition—if caught and managed in time. The recent approval of Resmetirom (Rezdiffra) has opened the door to targeted pharmacologic therapy that reduces liver fat and fibrosis in a meaningful way.

At the same time, a growing body of evidence supports the power of intermittent fasting (IF) to do the same—without medications, side effects, or cost.

But this article is not intended to replace medical advice or recommend stopping Resmetirom or any prescribed treatment. Instead, it highlights how intermittent fasting may serve as a powerful adjunct to conventional therapy.

For those already on Resmetirom, incorporating IF—especially Time-Restricted Eating or the 5:2 Diet—along with aerobic activity could amplify the benefits, improving metabolic health, lowering inflammation, and possibly accelerating liver recovery.

As always, any new lifestyle changes should be discussed with your doctor, especially if you have diabetes, take medications, or already have advanced liver disease.

Whether through medication, fasting, or both, the goal remains the same: to heal the liver before cirrhosis develops. And that healing, as we’ve seen, is within reach.

Don’t Get Sick!

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

References:

Harrison, Stephen A., et al. “Resmetirom for Nonalcoholic Steatohepatitis with Liver Fibrosis.” The New England Journal of Medicine, vol. 390, no. 6, 8 Feb. 2024, pp. 501–514. DOI: 10.1056/NEJMoa2308910.
American Journal of Managed Care. “FDA Approves Resmetirom, First Treatment for NASH With Liver Fibrosis.” AJMC, 14 Mar. 2024, https://www.ajmc.com/view/fda-approves-resmetirom-first-treatment-for-nash-with-liver-fibrosis.
Drugs.com. “Rezdiffra Prices, Coupons, and Patient Assistance Programs.” Drugs.com, 2024, https://www.drugs.com/price-guide/rezdiffra.
Ezpeleta, Mark et al. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial. Cell Metabolism, Volume 35, Issue 1, 56 – 70.e3
Yin C, Li Z, Xiang Y, Peng H, Yang P, Yuan S, Zhang X, Wu Y, Huang M, Li J. Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Front Nutr. 2021 Jul 12;8:709683. doi: 10.3389/fnut.2021.709683. PMID: 34322514; PMCID: PMC8310935. https://pmc.ncbi.nlm.nih.gov/articles/PMC8310935/
Khalafi, M., Rosenkranz, S.K., Ghasemi, F. et al. Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis. Nutr Metab (Lond) 22, 1 (2025). https://doi.org/10.1186/s12986-024-00885-x
Wang YY, Tian F, Qian XL, Ying HM, Zhou ZF. Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial. Front Nutr. 2024 Aug 20;11:1439473. doi: 10.3389/fnut.2024.1439473. PMID: 39229586; PMCID: PMC11368853. https://pubmed.ncbi.nlm.nih.gov/39229586/
Wei X, Lin B, Huang Y, Yang S, Huang C, Shi L, Liu D, Zhang P, Lin J, Xu B, Guo D, Li C, He H, Liu S, Xue Y, Xu Y, Zhang H. Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial. JAMA Netw Open. 2023 Mar 1;6(3):e233513. doi: 10.1001/jamanetworkopen.2023.3513. PMID: 36930148; PMCID: PMC10024204. https://pmc.ncbi.nlm.nih.gov/articles/PMC10024204/
Ozlu Karahan T, Yilmaz Akyuz E, Yilmaz Karadag D, Yilmaz Y, Eren F. Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. Life (Basel). 2025 Apr 25;15(5):696. doi: 10.3390/life15050696. PMID: 40430125; PMCID: PMC12113254. https://pmc.ncbi.nlm.nih.gov/articles/PMC12113254/
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Definition & Facts of NAFLD & NASH.” NIDDK, https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts.

As an Amazon Associate, I earn from qualifying purchases.

Discover more from Don't Get Sick!

Subscribe to get the latest posts sent to your email.

🟩 Introduction

🟨 II. What Is NAFLD and Its Stages?

🟢 Stage 1: Simple Steatosis (Fatty Liver)

🟡 Stage 2: NASH (Non-Alcoholic Steatohepatitis)

🟠 Stage 3: Fibrosis (Advanced NASH)

🔴 Stage 4: Cirrhosis

⚠️ Why Staging Matters

🟦 III. How Is Fatty Liver Monitored?

🖥️ A. Imaging Tests

1. Ultrasound

2. FibroScan (Transient Elastography)

3. MRI-PDFF (Proton Density Fat Fraction)

🧪 B. Blood-Based Tests

1. Liver Enzymes

2. Fibrosis Scoring Systems

🧬 C. Liver Biopsy

🔁 How Progress Is Measured Over Time

🟥 IV. The Dangers of Cirrhosis

🔄 What Happens in Cirrhosis?

⚠️ Health Risks of Cirrhosis

1. Liver Failure

2. Portal Hypertension

3. Hepatic Encephalopathy

4. Hepatocellular Carcinoma (Liver Cancer)

5. Need for Liver Transplant

🚨 Why Early Intervention Matters

🟪 V. What Is Resmetirom and How Does It Work?

🧪 What Kind of Drug Is It?

⚙️ How Does It Work?

📊 What Do the Clinical Trials Say?

💊 What Are the Side Effects?

💵 Accessibility and Cost

🟨 VI. How Does Intermittent Fasting Help Fatty Liver?

⚙️ How IF Works in the Liver

📚 Supporting Evidence

🕐 Types of Intermittent Fasting for NAFLD

🟠 1. Time-Restricted Eating (TRE)

🟡 2. 5:2 Diet

🔵 3. Alternate Day Fasting (ADF)

🏃‍♂️ Bonus: Add Aerobic Exercise

🔁 Summary of IF Effects on NAFLD

⚠️ One Common Mistake to Avoid

🟦 VII. Comparison Table: Resmetirom vs. Intermittent Fasting Approaches

✅ Key Takeaways:

🟩 VIII. Conclusion

Related:

References:

Share this:

Like this:

Discover more from Don't Get Sick!

Discover more from Don't Get Sick!